IP protection for pharmaceuticals

A growing and aging population is putting increased pressure on healthcare providers and innovators. Limited healthcare budgets are squeezing the value in the sector to innovators. It is therefore increasingly important that innovators obtain and defend a robust IP portfolio to protect their research and development assets. It is also crucial to monitor third-party rights that might disrupt the pharmaceutical value chain and clear the path where necessary.

How we can help

We are a focussed, specialist group representing and advising multinational companies, universities and spin-outs that carry out leading research and development to obtain, manage and defend their worldwide IP rights, as well as to challenge third-party IP rights. We also advise on due diligence, freedom to operate, patentability, infringement, and mergers and acquisitions matters.

We have a team of attorneys with technical backgrounds and experience in the chemical and biological fields to inform an expertise in medicinal chemistry and pharmacology. We also have a wealth of experience in brand protection. We have advised on a wide range of pharmaceutical matters relating to human and animal health.

We are ideally placed to protect your pharmaceutical technology via patents, supplementary protection certificates and trade marks.

Related reads

IP tips

28-07-2020

How to throw a spanner in the works for patent applicants — third party observations 101

Third party observations can cost-effectively influence the examination of patent applications.

Read more

Industry news

18-06-2020

UDL is one of the Financial Times’ 2020 Leading European Patent Law Firms

We’re delighted to be included in the Financial Times Europe’s Leading Patent Law Firms 2020.

Read more

Industry news

16-06-2020

2020 IAM Patent 1000 rankings – we’re recommended!

We’re delighted to announce we’re again ‘recommended’ in the IAM Patent 2020 rankings

Read more

Case studies

Case Study

Medisyne Ltd

How to patent software — avoiding patentability exclusions with AI and ML

We helped a client to secure vital funding and avoid notorious patentability exclusions by filing a patent to protect its software-focused technology.

Case Study

Anonymous medical client

Taking a scalpel to a European patent

We identified a fatal flaw and entirely revoked a competitor’s patent on the rare basis of insufficiency.

Case Study

Extract Technology

Securing patent rights before a product launch

When you need patents drafted quickly for a very technical product, it helps to bring in a real industry expert to get to grips with the invention.

Meet our team

Ian Byworth

Partner - Patents / Trade marks

Dr Simon Mitchell

Partner - Patents

Dr Neil Pawlyn

Managing Partner - Patents / Trade marks

Alison Simpson

Managing Partner - Patents / Trade marks

Mark Green

Consultant

Get in touch

Fill out our contact form and one of our team will be in touch.

Alternatively, contact us directly and speak to a member of our specialist team.

+44 330 107 5077

Enquiry Type (Optional)

Specifying your location will help us to find the right attorney for you

Please tell us a bit more about where you heard about us

For information about what we do with your personal data please see our Privacy Policy.

Website by Extreme